AR inhibition leading to the inactivation of the androgen-inducible promoter along with PIK3CB inactivation is expected to inhibit PCa with PTEN deletion and activating mutation of PIK3CB [70]. The gene discussed is PIK3CB; the disease is posterior cortical atrophy.